GeneBioTech Co Stock

GeneBioTech Co Acquisitions (Net)

Acquisitions (Net) of GeneBioTech Co (086060.KQ) as of Sep 7, 2026.

Acquisitions (Net)

0.00KRW

Last updated:

Acquisitions (Net) of GeneBioTech Co is 2026 0.00 KRW. Acquisitions (Net) of GeneBioTech Co was 2025 152.98 M KRW. It decreases by % lower compared to the previous year.

The GeneBioTech Co Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
-4.34 B KRW
Jan 1, 2018
-5.15 B KRW
Jan 1, 2019
1.31 B KRW
Jan 1, 2020
3.69 B KRW
Jan 1, 2021
9.02 B KRW
Jan 1, 2022
1.82 B KRW
Jan 1, 2023
-4.56 B KRW
Jan 1, 2024
152.98 M KRW
The GeneBioTech Co Acquisitions (Net) history
YEARAcquisitions (Net)YoY
152.98 MKRW-103.36%
-4.56 BKRW-349.93%
1.82 BKRW-79.79%
9.02 BKRW+144.49%
3.69 BKRW+182.83%
1.31 BKRW-125.37%
-5.15 BKRW+18.46%
-4.34 BKRW-397.11%
1.46 BKRW+200.72%
486.10 MKRW+14.86%
423.20 MKRW—
Access this data via the Eulerpool API
Get Free API Key

GeneBioTech Co Stock analysis

What does GeneBioTech Co do? GeneBioTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneBioTech Co stock

On Eulerpool you can find the complete historical development of Acquisitions (Net) GeneBioTech Co since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s GeneBioTech Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — GeneBioTech Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — GeneBioTech Co